Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma

SIMPLE SUMMARY: High-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a standard treatment in patients with newly diagnosed multiple myeloma (MM). At relapse, salvage HDCT/ASCT is a treatment option in patients with sufficient benefit from frontline HDCT/ASCT, but no evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Baertsch, Marc-Andrea, Fougereau, Mathilde, Hielscher, Thomas, Sauer, Sandra, Breitkreutz, Iris, Jordan, Karin, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Raab, Marc-Steffen, Hillengass, Jens, Giesen, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472377/
https://www.ncbi.nlm.nih.gov/pubmed/34572934
http://dx.doi.org/10.3390/cancers13184706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472377/
https://www.ncbi.nlm.nih.gov/pubmed/34572934
http://dx.doi.org/10.3390/cancers13184706

Ejemplares similares